Donnelley Financial Solutions (DFIN) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 14, 2025, to be held virtually for shareholders of record as of March 17, 2025.
Shareholders can access proxy materials online or request paper copies at no charge.
Voting matters and shareholder proposals
Election of eight director nominees for a one-year term is up for vote.
Advisory vote on executive compensation is included.
Proposal to amend the 2016 Performance Incentive Plan is on the agenda.
Ratification of Deloitte & Touche LLP as independent auditor is proposed.
Other business may be conducted if properly raised.
Board of directors and corporate governance
Eight nominees are identified for election to the board for a one-year term.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Donnelley Financial Solutions
- Q4 2025 net sales up 10.4% with strong software growth, margin expansion, and positive outlook.DFIN
Q4 202517 Feb 2026 - Record Q2 margin and software growth drove net earnings up 17% to $44.1M.DFIN
Q2 20242 Feb 2026 - Software growth offset print declines, with strong cash flow and continued share repurchases.DFIN
Q3 202417 Jan 2026 - Transitioning to a software-led model, targeting 60% software sales by 2028 and higher margins.DFIN
28th Annual Needham Growth Conference Virtual13 Jan 2026 - Software growth and margin gains offset weak capital markets; share buybacks boost flexibility.DFIN
Q1 202524 Dec 2025 - Software solutions growth led to margin expansion and strong cash flow, offsetting print declines.DFIN
Q4 202423 Dec 2025 - Software solutions led revenue growth in 2024, with key votes on compensation, governance, and ESG.DFIN
Proxy Filing1 Dec 2025 - Record software sales and strong cash flow offset declines in print and transactional revenue.DFIN
Q2 202516 Nov 2025 - Software growth and margin gains offset sales decline; pension charge led to net loss.DFIN
Q3 202530 Oct 2025